Featured Research

from universities, journals, and other organizations

Incisionless Procedure To Reduce Weight Regain After Gastric Bypass Surgery

Date:
May 21, 2008
Source:
University of California, San Diego Health Sciences
Summary:
Every year more than 100,000 U.S. patients undergo gastric bypass surgery for the treatment of obesity. Experience now shows approximately 20 percent of these patients will regain weight within a few years after the surgery, due to the stretching of the stomach, and will be at renewed risk for diseases such as hypertension, diabetes, and cardiovascular disease. The Center for the Treatment of Obesity at UC San Diego Medical Center now offers a new incision-free procedure to reverse weight gain after gastric bypass surgery.

Every year more than 100,000 U.S. patients undergo gastric bypass surgery for the treatment of obesity. Experience now shows approximately 20 percent of these patients will regain weight within a few years after the surgery, due to the stretching of the stomach, and will be at renewed risk for diseases such as hypertension, diabetes, and cardiovascular disease. The Center for the Treatment of Obesity at UC San Diego Medical Center now offers a new incision-free procedure to reverse weight gain after gastric bypass surgery.

“To date, procedures to revise gastric bypass surgeries have been expensive and difficult to perform, effectively leaving patients without any treatment options,” said Santiago Horgan, M.D., director of the UC San Diego Center for the Treatment of Obesity. “Now, with this procedure, we have a dramatically less invasive way to correct a key cause of weight regain.”

Horgan and Garth Jacobsen, M.D., performed California’s first such surgery on Wednesday, May 14, 2008. The procedure, called “ROSE” (Restorative Obesity Surgery, Endolumenal), uses instruments inserted through the mouth to reduce the size of a patient’s stomach pouch and the opening to the small intestine to help patients achieve weight loss again.

To perform the scarless procedure, a small, flexible endoscope and surgical tools are inserted through the mouth and into the stomach pouch. The tools, developed by USGI Medical Inc., are used to grasp, fold and stitch tissue to reduce the diameter of the stomach opening and the volume of the stomach pouch. No cuts are made into the patient’s skin during the procedure.

By eliminating skin incisions, this minimally-invasive procedure offers important advantages to patients including reduced risk of infection, less post-operative pain, faster recovery time, and no abdominal scars.

Ideal candidates for the surgery are patients who were initially successful losing weight after their gastric bypass and now are regaining weight. After an initial screening, patients undergo a series of evaluations including nutritional and dietary counseling, a full medical exam, and endoscopy.

More than 15 million people in the United States suffer from severe obesity. Surgical treatment of obesity has increased significantly in recent years. Over 200,000 individuals in the United States undergo bariatric surgery each year, and it is estimated that over 125,000 patients today are candidates waiting for a revision procedure.

The Center for the Treatment of Obesity at UC San Diego Medical Center makes a long-term commitment to patients’ health and guides them from pre-surgery consultation and testing through surgery, recovery and continuing support. The program specializes in laparoscopic weight-loss surgery, including adjustable gastric lap banding and Roux-en-y Gastric Bypass.


Story Source:

The above story is based on materials provided by University of California, San Diego Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of California, San Diego Health Sciences. "Incisionless Procedure To Reduce Weight Regain After Gastric Bypass Surgery." ScienceDaily. ScienceDaily, 21 May 2008. <www.sciencedaily.com/releases/2008/05/080520160855.htm>.
University of California, San Diego Health Sciences. (2008, May 21). Incisionless Procedure To Reduce Weight Regain After Gastric Bypass Surgery. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/05/080520160855.htm
University of California, San Diego Health Sciences. "Incisionless Procedure To Reduce Weight Regain After Gastric Bypass Surgery." ScienceDaily. www.sciencedaily.com/releases/2008/05/080520160855.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins